These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 16363319)
1. Leukocyte removal efficiency of cell-washed and unwashed whole blood: an in vitro study. ten Brinke MJ; Weerwind PW; Teerenstra S; Feron JC; van der Meer W; Brouwer MH Perfusion; 2005 Oct; 20(6):335-41. PubMed ID: 16363319 [TBL] [Abstract][Full Text] [Related]
2. The Haemonetics Cell Saver 5 washing properties: effect of different washing pump and centrifuge speeds. Naumenko KS; Kim SF; Cherkanova MS; Naumenko SE Interact Cardiovasc Thorac Surg; 2008 Oct; 7(5):759-63. PubMed ID: 18635585 [TBL] [Abstract][Full Text] [Related]
3. Leukocyte depletion results in improved lung function and reduced inflammatory response after cardiac surgery. Gu YJ; de Vries AJ; Boonstra PW; van Oeveren W J Thorac Cardiovasc Surg; 1996 Aug; 112(2):494-500. PubMed ID: 8751518 [TBL] [Abstract][Full Text] [Related]
4. Clinical performance of a high-efficiency rapid flow leucocyte removal filter for leucocyte depletion of heparinized cardiopulmonary bypass perfusate. Gu YJ; deVries AJ; Boonstra PW; van Oeveren W Perfusion; 1995 Nov; 10(6):425-30. PubMed ID: 8747899 [TBL] [Abstract][Full Text] [Related]
5. Activation of neutrophils and monocytes by a leukocyte-depleting filter used throughout cardiopulmonary bypass. Ilmakunnas M; Pesonen EJ; Ahonen J; Rämö J; Siitonen S; Repo H J Thorac Cardiovasc Surg; 2005 Apr; 129(4):851-9. PubMed ID: 15821654 [TBL] [Abstract][Full Text] [Related]
6. A Novel Centrifugation Method Using a Cell Salvage Device Offers an Alternative to the Use of Leukocyte-Depleting Filters for Autologous Blood Transfusions. Barchilon M; Gaspar C; Mexas A; Nieter D J Extra Corpor Technol; 2016 Dec; 48(4):168-172. PubMed ID: 27994256 [TBL] [Abstract][Full Text] [Related]
7. [The effect of two leukocyte depletion in-line filters on the efficiency of whole blood filtration]. Xie R; Li Y; Huang Y; Mo Q; Dai Y; Tang W Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2007 Aug; 24(4):817-9. PubMed ID: 17899752 [TBL] [Abstract][Full Text] [Related]
8. [The dynamics of blood composition changes in leukocyte filtration during cardiopulmonary bypass. Preliminary results]. Mihaljevic T; Tönz M; Pasic M; Engel M; von Segesser LK; Turina M Helv Chir Acta; 1993 Dec; 60(3):403-6. PubMed ID: 8119822 [TBL] [Abstract][Full Text] [Related]
12. [The pulmonary protective effects of leukocyte depletion with a modified filter located at the cardiopulmonary bypass (CPB) venous line in canine]. Li Q; Chen HJ; Du L; Zhou L; Wang Y; Liu B Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Sep; 36(5):723-6. PubMed ID: 16235549 [TBL] [Abstract][Full Text] [Related]
13. A laboratory study of the effects of processing blood through a cell salvage device and leucocyte depletion filter on levels of pro-inflammatory cytokines and bradykinin. Choi ES; Ahn WS; Lee JM; Jeon JK; Kim HC; Lim YJ; Sim JY Anaesthesia; 2013 Dec; 68(12):1259-65. PubMed ID: 24219252 [TBL] [Abstract][Full Text] [Related]
14. Processing and transfusion of residual cardiopulmonary bypass volume: effects on haemostasis, complement activation, postoperative blood loss and transfusion volume. Daane CR; Golab HD; Meeder JH; Wijers MJ; Bogers AJ Perfusion; 2003 Apr; 18(2):115-21. PubMed ID: 12868789 [TBL] [Abstract][Full Text] [Related]
15. Clinical efficacy and biocompatibility of three different leukocyte and fat removal filters during cardiac surgery. de Vries AJ; Vermeijden WJ; Gu YJ; Hagenaars JA; van Oeveren W Artif Organs; 2006 Jun; 30(6):452-7. PubMed ID: 16734597 [TBL] [Abstract][Full Text] [Related]
16. Does leukodepletion during elective cardiac surgery really influence the overall clinical outcome? Efstathiou A; Vlachveis M; Tsonis G; Asteri T; Psarakis A; Fessatidis IT J Cardiovasc Surg (Torino); 2003 Apr; 44(2):197-204. PubMed ID: 12813383 [TBL] [Abstract][Full Text] [Related]
17. [Effects of leukocyte depletion filter on canine kidney during cardiopulmonary bypass]. Yang YB; Zhu ZQ; Zheng H; Du L; Huang SM Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Jun; 30(3):321-4. PubMed ID: 16045024 [TBL] [Abstract][Full Text] [Related]
18. The potential of the novel leukocyte removal filter in cardiopulmonary bypass. Fujii Y Expert Rev Med Devices; 2016; 13(1):5-14. PubMed ID: 26613267 [TBL] [Abstract][Full Text] [Related]
19. The GP IIb/IIIa inhibitor abciximab (ReoPro) decreases activation and interaction of platelets and leukocytes during in vitro cardiopulmonary bypass simulation. Straub A; Wendel HP; Azevedo R; Ziemer G Eur J Cardiothorac Surg; 2005 Apr; 27(4):617-21. PubMed ID: 15784360 [TBL] [Abstract][Full Text] [Related]
20. Efficacy of leukocyte depletion of residual pump blood. Heerdt EM; Fransen EJ; Maessen JG; de Jong DS Perfusion; 2004 Jan; 19(1):3-5. PubMed ID: 15072248 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]